ARCHIVES

House-Senate Conferees agree On NCI Total for FY’89, Then Cut It $19 Million

This article is from The Cancer Letter archive.

Vol. 14 No. 35 | August 26, 1988

Download PDF Visit The Full Archive

Related Articles

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

DeVita Reshuffling NCI Office Space

April 18, 1980

User Fees Proposed For FDA Oversight Services; Industry Groups Call It “Tax On Innovations”

January 20, 1989

ICF Clement Joins Dynalectron In FCRF

January 9, 1987

Mozobil Plus G-CSF Increases Rate Of Cell Mobilization

September 30, 2005

In Brief: Ahoy! It’s “Admiral Rick”

April 2, 1999